Karen Slobod

发表

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.

A. Falsey, S. Stoszek, A. Baqui, 2023, The New England journal of medicine.

Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial

C. Griffin, Honghong Zhou, B. Girard, 2024, The Lancet Infectious Diseases.